1. Home
  2. HSDT vs ORGO Comparison

HSDT vs ORGO Comparison

Compare HSDT & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Helius Medical Technologies Inc. (DE)

HSDT

Helius Medical Technologies Inc. (DE)

N/A

Current Price

$1.67

Market Cap

155.6M

Sector

Health Care

ML Signal

N/A

Logo Organogenesis Holdings Inc.

ORGO

Organogenesis Holdings Inc.

N/A

Current Price

$0.79

Market Cap

125.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HSDT
ORGO
Founded
N/A
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
155.6M
125.3M
IPO Year
2014
2016

Fundamental Metrics

Financial Performance
Metric
HSDT
ORGO
Price
$1.67
$0.79
Analyst Decision
Buy
Analyst Count
2
0
Target Price
★ $3.00
N/A
AVG Volume (30 Days)
562.2K
★ 1.0M
Earning Date
11-11-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
57.27
★ 1600.00
EPS
★ N/A
N/A
Revenue
$6,017,000.00
★ $564,169,000.00
Revenue This Year
$104.42
N/A
Revenue Next Year
$15.45
$37.55
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 1057.12
17.04
52 Week Low
$1.19
$0.73
52 Week High
$4.36
$5.91

Technical Indicators

Market Signals
Indicator
HSDT
ORGO
Relative Strength Index (RSI) 29.28 38.58
Support Level $1.61 $0.73
Resistance Level $1.85 $1.06
Average True Range (ATR) 0.12 0.10
MACD -0.03 0.01
Stochastic Oscillator 16.90 19.06

Price Performance

Historical Comparison
HSDT
ORGO

About HSDT Helius Medical Technologies Inc. (DE)

Solana Co is a publicly listed digital asset treasury established in partnership with Pantera and Summer Capital. The company is dedicated to acquiring Solana (SOL) and aims to maximize SOL per share by strategically leveraging capital market opportunities and on-chain activities.

About ORGO Organogenesis Holdings Inc.

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

Share on Social Networks: